BLFS – BioLife Solutions, Inc.
BioLife Solutions, Inc.BLFS
$21.49Name : BioLife Solutions, Inc.
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $1,022,090,176.00
EPSttm : -0.19
BioLife Solutions, Inc.
$21.49
0.05%$0.01Float Short %
9.55
Margin Of Safety %
-16
Put/Call OI Ratio
0.76
EPS Next Q Diff
0.01
EPS Last/This Y
0.46
EPS This/Next Y
0.14
Price
21.49
Target Price
31.22
Analyst Recom
1
Performance Q
-17.88
Relative Volume
1.59
Beta
1.81
Ticker: BLFS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | BLFS | 20.65 | 1.45 | 100.00 | 255 |
| 2025-06-03 | BLFS | 21.37 | 1.45 | 102.33 | 255 |
| 2025-06-04 | BLFS | 22 | 1.45 | 102.33 | 255 |
| 2025-06-05 | BLFS | 21.49 | 1.45 | 102.33 | 255 |
| 2025-06-06 | BLFS | 23.75 | 4.40 | 0.00 | 562 |
| 2025-06-09 | BLFS | 23.83 | 4.45 | 0.00 | 561 |
| 2025-06-10 | BLFS | 23.95 | 4.45 | 0.00 | 561 |
| 2025-06-11 | BLFS | 23.71 | 4.45 | 0.00 | 561 |
| 2025-06-12 | BLFS | 23.26 | 4.45 | 0.00 | 561 |
| 2025-06-13 | BLFS | 21.99 | 4.32 | 999.99 | 564 |
| 2025-06-16 | BLFS | 22.28 | 4.36 | 999.99 | 568 |
| 2025-06-17 | BLFS | 21.75 | 4.35 | 0.00 | 567 |
| 2025-06-18 | BLFS | 21.53 | 4.31 | 0.00 | 568 |
| 2025-06-20 | BLFS | 21.19 | 4.27 | 0.00 | 569 |
| 2025-06-23 | BLFS | 21.36 | 0.78 | 0.33 | 158 |
| 2025-06-24 | BLFS | 21.78 | 0.78 | 0.27 | 158 |
| 2025-06-25 | BLFS | 21.29 | 0.78 | 0.00 | 164 |
| 2025-06-26 | BLFS | 21.44 | 0.77 | 0.00 | 166 |
| 2025-06-27 | BLFS | 21.51 | 0.76 | 0.67 | 167 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | BLFS | 20.65 | 85.2 | - | 0.02 |
| 2025-06-03 | BLFS | 21.38 | 85.2 | - | 0.02 |
| 2025-06-04 | BLFS | 22.01 | 85.2 | - | 0.02 |
| 2025-06-05 | BLFS | 21.50 | 85.2 | - | 0.02 |
| 2025-06-06 | BLFS | 23.73 | 85.2 | - | 0.02 |
| 2025-06-09 | BLFS | 23.84 | 85.2 | - | 0.02 |
| 2025-06-10 | BLFS | 23.94 | 85.2 | - | 0.02 |
| 2025-06-11 | BLFS | 23.76 | 85.2 | - | 0.02 |
| 2025-06-12 | BLFS | 23.30 | 85.2 | - | 0.02 |
| 2025-06-13 | BLFS | 22.03 | 85.2 | - | 0.02 |
| 2025-06-16 | BLFS | 22.29 | 85.2 | - | 0.02 |
| 2025-06-17 | BLFS | 21.73 | 85.2 | - | 0.02 |
| 2025-06-18 | BLFS | 21.52 | 85.2 | - | 0.02 |
| 2025-06-20 | BLFS | 21.22 | 85.2 | - | 0.02 |
| 2025-06-23 | BLFS | 21.36 | 85.2 | - | 0.02 |
| 2025-06-24 | BLFS | 21.79 | 85.2 | - | 0.02 |
| 2025-06-25 | BLFS | 21.31 | 85.2 | - | 0.02 |
| 2025-06-26 | BLFS | 21.47 | 85.2 | - | 0.02 |
| 2025-06-27 | BLFS | 21.49 | 85.2 | - | 0.02 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | BLFS | -7.98 | 2.53 | 9.10 |
| 2025-06-03 | BLFS | -7.98 | 2.53 | 9.10 |
| 2025-06-04 | BLFS | -7.98 | 2.53 | 9.10 |
| 2025-06-05 | BLFS | -7.82 | 2.53 | 9.11 |
| 2025-06-06 | BLFS | -7.82 | 2.53 | 9.11 |
| 2025-06-09 | BLFS | -7.82 | 2.56 | 9.11 |
| 2025-06-10 | BLFS | -7.94 | 2.56 | 9.11 |
| 2025-06-11 | BLFS | -7.94 | 2.56 | 10.26 |
| 2025-06-12 | BLFS | -7.94 | 2.56 | 10.26 |
| 2025-06-13 | BLFS | -37.67 | 2.56 | 10.26 |
| 2025-06-16 | BLFS | -37.67 | 2.50 | 10.26 |
| 2025-06-18 | BLFS | -37.67 | 2.50 | 10.26 |
| 2025-06-20 | BLFS | -37.26 | 2.50 | 10.26 |
| 2025-06-23 | BLFS | -37.26 | -0.30 | 10.26 |
| 2025-06-24 | BLFS | -37.26 | -0.30 | 10.26 |
| 2025-06-25 | BLFS | -37.26 | -0.30 | 10.26 |
| 2025-06-26 | BLFS | -37.26 | -0.30 | 9.55 |
| 2025-06-27 | BLFS | -37.26 | -0.30 | 9.55 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.01
Avg. EPS Est. Current Quarter
-0.01
Avg. EPS Est. Next Quarter
-0.01
Insider Transactions
-37.26
Institutional Transactions
-0.3
Beta
1.81
Average Sales Estimate Current Quarter
23
Average Sales Estimate Next Quarter
24
Fair Value
18.05
Quality Score
46
Growth Score
47
Sentiment Score
41
Actual DrawDown %
64.6
Max Drawdown 5-Year %
-85.1
Target Price
31.22
P/E
Forward P/E
247.47
PEG
P/S
9.68
P/B
2.9
P/Free Cash Flow
88.19
EPS
-0.04
Average EPS Est. Cur. Y
0.02
EPS Next Y. (Est.)
0.16
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1.44
Relative Volume
1.59
Return on Equity vs Sector %
-26.9
Return on Equity vs Industry %
-11.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
BioLife Solutions, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 159
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
stock quote shares BLFS – BioLife Solutions, Inc. Stock Price stock today
news today BLFS – BioLife Solutions, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BLFS – BioLife Solutions, Inc. yahoo finance google finance
stock history BLFS – BioLife Solutions, Inc. invest stock market
stock prices BLFS premarket after hours
ticker BLFS fair value insiders trading